Gene · 8317
Papers1,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,550
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNAs Regulate Function in Atherosclerosis and Clinical Implications. | Oxid Med Cell Longev | 2023 | 37675243 | PubTator, text mining | PubMed |
| Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK Inhibitor. | Cancer Res Commun | 2023 | 37663435 | PubTator, text mining | PubMed |
| KIF11 serves as a cell cycle mediator in childhood acute lymphoblastic leukemia. | J Cancer Res Clin Oncol | 2023 | 37656243 | PubTator, text mining | PubMed |
| DONSON facilitates Cdc45 and GINS chromatin association and is essential for DNA replication initiation. | Nucleic Acids Res | 2023 | 37638758 | PubTator, text mining | PubMed |
| MBC and ECBL libraries: outstanding tools for drug discovery. | Front Pharmacol | 2023 | 37637414 | PubTator, text mining | PubMed |
| Computational analysis of regulatory regions in human protein kinases. | Protein Sci | 2023 | 37632170 | PubTator, text mining | PubMed |
| TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer's disease patients. | Front Mol Neurosci | 2023 | 37621404 | PubTator, text mining | PubMed |
| Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal. | Genome Biol | 2023 | 37612728 | PubTator, text mining | PubMed |
| Identification of Selective ATP-Competitive CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome Function. | Res Sq | 2023 | 37609279 | PubTator, text mining | PubMed |
| Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma. | Front Immunol | 2023 | 37600810 | PubTator, text mining | PubMed |
| Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma. | Asian J Pharm Sci | 2023 | 37583709 | PubTator, text mining | PubMed |
| The metabolic control of DNA replication: mechanism and function. | Open Biol | 2023 | 37582405 | PubTator, text mining | PubMed |
| SETD1A drives stemness by reprogramming the epigenetic landscape in hepatocellular carcinoma stem cells. | JCI Insight | 2023 | 37581938 | PubTator, text mining | PubMed |
| Role of TRP Channels in Liver-Related Diseases. | Int J Mol Sci | 2023 | 37569884 | PubTator, text mining | PubMed |
| MAGI1 Prevents Senescence and Promotes the DNA Damage Response in ER+ Breast Cancer. | Cells | 2023 | 37566008 | PubTator, text mining | PubMed |
| Nanomedical research and development in Spain: improving the treatment of diseases from the nanoscale. | Front Bioeng Biotechnol | 2023 | 37545884 | PubTator, text mining | PubMed |
| Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers. | Sci Transl Med | 2023 | 37531417 | PubTator, text mining | PubMed |
| SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response. | Nat Genet | 2023 | 37524790 | PubTator, text mining | PubMed |
| Minichromosome maintenance proteins in lung adenocarcinoma: Clinical significance and therapeutic targets. | FEBS Open Bio | 2023 | 37517032 | PubTator, text mining | PubMed |
| The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies. | Molecules | 2023 | 37513232 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8317/papers?page=6